Elliott P. Joslin
Elliott P. Joslin[edit | edit source]
Elliott Proctor Joslin (June 6, 1869 – January 28, 1962) was an American diabetologist and a pioneer in the study and treatment of diabetes mellitus. He is considered one of the most influential figures in the field of diabetes care and management.
Early Life and Education[edit | edit source]
Elliott P. Joslin was born in Oxford, Massachusetts, in 1869. He attended Yale University, where he graduated with a degree in arts in 1890. He then pursued a medical degree at Harvard Medical School, graduating in 1895. During his time at Harvard, Joslin developed a keen interest in the study of diabetes, which was a poorly understood condition at the time.
Career[edit | edit source]
After completing his medical education, Joslin began his practice in Boston, where he focused on the treatment of diabetes. He was one of the first physicians to advocate for the importance of patient education and self-management in diabetes care. Joslin believed that patients should be actively involved in their own treatment, a philosophy that was revolutionary at the time.
Contributions to Diabetes Care[edit | edit source]
Joslin's approach to diabetes management emphasized the importance of diet, exercise, and insulin therapy. He was a strong proponent of the "metabolic balance" approach, which aimed to maintain normal blood sugar levels through careful monitoring and lifestyle adjustments.
In 1916, Joslin published "The Treatment of Diabetes Mellitus," which became a seminal text in the field. The book outlined his comprehensive approach to diabetes care and was widely used by physicians and patients alike.
Joslin Diabetes Center[edit | edit source]
In 1952, Joslin founded the Joslin Diabetes Center in Boston, which became a leading institution for diabetes research, education, and treatment. The center continues to be at the forefront of diabetes care and innovation.
Legacy[edit | edit source]
Elliott P. Joslin's work laid the foundation for modern diabetes management. His emphasis on patient education and self-care has had a lasting impact on the field. The Joslin Diabetes Center remains a testament to his contributions and continues to honor his legacy by advancing diabetes research and treatment.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD